You are cordially invited to join us for our first 2012 New England Clinical Operations Executive Breakfast Forum.
Social Media is a powerful and efficient tool for communicating to friends, colleagues, or patients. It has the potential to impact subject recruitment in clinical trials, but it should be considered along with other strategies.
While the FDA has issued a guidance on recruiting study subjects for IRBs and Clinical Investigators using traditional forms of media advertising, it has remained quiet on the use of social media for subject recruitment. To date, the FDA has only made promises of upcoming guidance on the use of the internet and social media for promotion of FDA-regulated medical products.
This is an area with much promise but no clearcut methodologies; potential legal and ethical issues abound which we will explore in our first 2012 meeting.
Questions open for discussion include:
- How do you determine whether social media will be part of your recruitment planning?
- Are there vendors who are experts at guiding you through the process?
- What is legal's involvement in the effort?
- What support do you offer the research sites to gain approval from their ethics committees?
- How about communication directly with patients after the trial?
- What pitfalls should you try and avoid and how?
Come and share your best practices, lessons learned, simple fixes and all other operational challenges at our first breakfast of the new year.
Presenters Include:
Ken Getz, Fellow, Tufts Center for Drug Development
Andrea DiFabio, VP, Chief Research and Development Counsel, Biogen Idec
Troy Morgan, Senior Director, Corporate Compliance, Biogen Idec
For more information about this breakfast or for an invitation to one of our events, please contact Abbi Baranski at abaranski@hallorancg.com.